Skip to content

One-a-day regimens mean better adherence for patients starting HIV treatment

Lack of perceived need for HIV treatment associated with poor adherence

Single dose of intravenous zoledronate shown to treat bone loss effectively for one year

Adherence of 80-95% not good enough for long-term treatment success in British Columbia HIV patients

Southern Africa: a long road to male circumcision

HIV testing for mothers and children must expand, UN report shows

Treatment breaks set for a come-back?

Modern HIV treatment can work well with adherence below 95%

Discrimination and distrust not sufficient to explain racial differences in adherence: US study